Oramed Pharmaceuticals Inc. (ORMP)

NASDAQ: ORMP · Real-Time Price · USD

3.880

+0.020 (0.52%)

At close: Apr 17, 2026, 4:00 PM EDT

3.853

-0.027 (-0.71%)

After-hours: Apr 17, 2026, 7:41 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021	FY 2020	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Aug '21 Aug 31, 2021	Dec '20 Dec 31, 2020	Aug '20 Aug 31, 2020	Aug '19 Aug 31, 2019	Aug '18 Aug 31, 2018
Research and Development Activities Related to its Proprietary Products and Technologies	2.00M		1.34M	2.70M	2.71M	2.70M
Research and Development Activities Related to its Proprietary Products and Technologies Growth	-		-50.43%	-0.33%	0.33%	-0.33%
Total	2.00M		1.34M	2.70M	2.71M	2.70M
Total Growth	-		-50.43%	-0.33%	0.33%	-0.33%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021	FY 2020	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Aug '21 Aug 31, 2021	Dec '20 Dec 31, 2020	Aug '20 Aug 31, 2020	Aug '19 Aug 31, 2019	Aug '18 Aug 31, 2018
Israel	2.00M		1.34M	2.70M	2.71M	2.70M
Israel Growth	-		-50.43%	-0.33%	0.33%	-0.33%
Total	2.00M		1.34M	2.70M	2.71M	2.70M
Total Growth	-		-50.43%	-0.33%	0.33%	-0.33%

Source: S&P Global Market Intelligence.